Consolidated revenues up to €273.2 million (+6.5%), EBITDA stands at  €41.7 million (+24.5%); EBIT up to €13.4 million and net profit up to €6.2 million. Sales increased in all business lines, especially in the ultrasound segment (+9.7%). Second consecutive record sales year for MRI (+3.3%). Continued expansion phase: average annual growth of 7.6% over the last 4 years. Esaote firmly among the world's leading medical imaging manufacturers with a strategy focused on innovation, quality, people and product portfolio differentiation. Strengthened presence in international markets representing 64.5% of total revenues. Invested €32.9 million in R&D. Continued commitment to Sustainability. GENOA, Italy, April 24, 2024 /CNW/ -- The Shareholders' Meeting of Esaote S.p.A., met today in Genoa, approved the company's financial statements as of 31.12.2023. All the main Group consolidated figures for ...